Blog

High-throughput, scalable SNP and indel marker development and screening with PACE genotyping reagents on the Biomark X9 System

High-throughput, scalable SNP and indel marker development and screening with PACE genotyping reagents on the Biomark X9 System

The Biomark™ X9 System for High-Throughput Genomics and PACE® chemistry present an unparalleled solution for large-scale, cost-effective PCR analysis, facilitating high-throughput, scalable single-nucleotide polymorphism (SNP) and insertion/deletion (indel) marker development. Using PACE chemistry with the Biomark X9™ System for marker discovery results in user-friendly marker sets for extensive screening, with applications spanning agricultural genomics, marker-assisted breeding, and pathogen screening.

Biomark X9 System and PACE Technology: Key Features and Benefits

The Biomark X9 System uses microfluidics technology and oers automated, high-performance PCR at nanoliter volumes, allowing simultaneous monitoring of multiple SNPs and indels across numerous samples. PACE, the latest in allele-specific chemistry, provides consistent performance, making it ideal for high-throughput genotyping, screening, pathogen detection, and biomonitoring. PACE genotyping reagents oer sensitive, accurate allele specific PCR detection with excellent performance, flexibility, and scalability.

PACE® SNP genotyping assay diagram with DNA sample, allele-specific forward primers (FAM and HEX), reverse primer and PCR master mix
Figure 1. Components of a PACE genotyping reaction

Synergistic Features and Benefits

The synergy of the Biomark X9 System and PACE technology amplifies cost-effective, high-throughput PCR analysis with thermal cycling and fluorescence detection using integrated fluidic circuits (IFCs). The combination allows the development of platform agnostic marker sets, utilizing existing assays with PACE genotyping reagents. Enhanced specificity and sensitivity, universal reporting, and compatibility with various throughput platforms ensure future-proofing, automation, and reproducibility.

Applications

The combination of the Biomark X9 System and PACE chemistry can be used in SNP genotyping, variant discovery mapping, linkage map construction, genetic diversity studies, and population studies. Additionally, it is well suited for parental selection, hybrid breeding, quality control in seed production, and pathogen detection, offering a versatile tool for a wide range of research and breeding strategies.

Figure 2. An example high-throughput genotyping workflow with the new Biomark X9 System

Example Use Case Study

Next-generation sequencing (NGS) for SNP discovery followed by PACE SNP marker saturation in quantitative trait loci (QTL) intervals exemplify the utility of this combination. Designing PACE genotyping assays against SNP variants, high throughput screening using the Biomark X9 System, and genotyping recombinants on lower-throughput platforms demonstrate the versatility in research and breeding applications.

Example Use Case Study Data Plot

Data below is taken from a study generated by a high-throughput genotyping and sequencing technology service provider for a public research institute. The example study saw 96 samples run across 96 SNPs, demonstrating tight clustering and high concordance of SNPs. The representative data showcases the accuracy and reliability of using PACE chemistry on the Biomark X9 System.

A

B

Figure 3. Example data of 96 samples over 96 SNPs. Data calling (A) from the heat map (B) shows tight clustering and a high concordance of SNPs in the principal component analysis plot.

Summary and Conclusion

The integration of the Biomark X9 System with PACE SNP and indel genotyping provides a powerful and versatile solution for animal and plant breeding workflows. Offering high-throughput genotyping, precise marker identification, and diverse applications, this approach stands as a cornerstone for advancements in genomics and breeding technologies.

MORE POSTS

High-throughput, scalable SNP and indel marker development and screening with PACE genotyping reagents on the Biomark X9 System
Learn how Biomark X9 and PACE technology enable scalable, high-throughput SNP genotyping for modern genomics and breeding workflows.
Outsourcing SNP Genotyping: When Does It Make Sense?
Should you build an in-house SNP genotyping lab or outsource it? Discover when outsourcing accelerates research, reduces costs, and improves scalability.
Plant DNA Extraction Kits: Challenges, Troubleshooting and Best Practices
Plant DNA extraction can be challenging — learn how to optimise DNA extraction kits for difficult tissues, seeds, and inhibitor-rich plant species.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Stay up to date with all things 3CR. 

Sign up now to receive insights, updates 
and industry case studies. 

This field is for validation purposes and should be left unchanged.
Name(Required)

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.